Syncom Healthcare IPO GMP History
Syncom Healthcare IPO has been listed on February 15, 2010 at a listing price of ₹89.9, against the issue price of ₹75 — a gain of ₹14.9 (+19.87%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Syncom Healthcare IPO raised ₹56.25 Cr. through its IPO at a price band of ₹65 to ₹75 per share, with a lot size of 90 shares. The IPO was open for subscription from 27 Jan 2010 to 29 Jan 2010.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:08 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Syncom Healthcare IPO dates
Key dates from opening to listing. Today is 12 November.
- Open 27 Jan 2010
- Close 29 Jan 2010
- Allotment 05 Feb 2010
- Refund/credit TBA
- Listing 15 Feb 2010
Syncom Healthcare IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹75 |
|---|---|
| Listing gain / loss | +₹14.9 per share |
| Listing date | 15 Feb, 2010 |
| Actual listing price | ₹89.9 (+19.87%) |
Is Syncom Healthcare IPO GMP reliable?
Grey market premium for Syncom Healthcare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Syncom Healthcare IPO full review for a fundamentals-based assessment before making any grey market trades.
Syncom Healthcare IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Syncom Healthcare IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Syncom Healthcare IPO
Syncom Healthcare Limited was originally incorporated on 29 July 2002 with the Registrar of Companies, Maharashtra, Mumbai. Its promoters are Ajay Bankda and Jyoti Bankda.
It makes, markets and trades pharmaceutical formulations in tablets, capsules, liquids, ointments, eye and ear drops, dry syrups and herbal products. It had over 250 products under its own brands.
It also works as a contract manufacturer for domestic and multinational companies, with a range of over 400 products, and its manufacturing premises span over 1,25,000 sq ft.
The IPO was Rs 56.25 crore and was entirely fresh issue at Rs 75 per share. The money was planned for a new unit at the Indore SEZ, upgrading its Dehradun plant, working capital and an export office in Mumbai.
Frequently asked
What is the GMP of Syncom Healthcare IPO?
The current Grey Market Premium (GMP) of Syncom Healthcare IPO is not yet started or active in the market.
What is the Kostak Price of Syncom Healthcare IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Syncom Healthcare IPO is not available.
What is the Subject to Sauda Price of Syncom Healthcare IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Syncom Healthcare IPO?
Syncom Healthcare IPO listed on February 15, 2010 at ₹89.9, against the issue price of ₹75 — a gain of +19.87%.
How did the GMP of Syncom Healthcare IPO trend before listing?
The GMP of Syncom Healthcare IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Syncom Healthcare IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
